14-23390361-C-T
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_002471.4(MYH6):c.3428G>A(p.Arg1143Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000392 in 1,608,354 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1143W) has been classified as Uncertain significance.
Frequency
Consequence
NM_002471.4 missense
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 14Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- Keppen-Lubinsky syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atrial septal defect 3Inheritance: AD Classification: LIMITED Submitted by: G2P
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH6 | NM_002471.4 | c.3428G>A | p.Arg1143Gln | missense_variant | Exon 26 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYH6 | ENST00000405093.9 | c.3428G>A | p.Arg1143Gln | missense_variant | Exon 26 of 39 | 5 | NM_002471.4 | ENSP00000386041.3 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151758Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000793 AC: 19AN: 239592 AF XY: 0.000114 show subpopulations
GnomAD4 exome AF: 0.0000405 AC: 59AN: 1456480Hom.: 0 Cov.: 34 AF XY: 0.0000580 AC XY: 42AN XY: 724654 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151874Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74260 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 28611029, 27930701, 36964972) -
The MYH6 p.Arg1143Gln variant was identified in 2 of 1688 proband chromosomes (frequency: 0.00119) from one individual with cardiovascular disease and another individual with sudden unexplained death (Sanchez_2016_PMID:27930701; Haskell_2017_PMID:28611029). The variant was identified in dbSNP (ID: rs543585784) and ClinVar (classified as VUS by Illumina, Ambry Genetics and Laboratory for Molecular Medicine). The variant was not identified in COSMIC or LOVD 3.0. The variant was identified in control databases in 19 of 239592 chromosomes (0 homozygous) at a frequency of 0.000079 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the following populations: South Asian in 13 of 30216 chromosomes (freq: 0.00043), East Asian in 1 of 17930 chromosomes (freq: 0.000056), European (non-Finnish) in 4 of 108002 chromosomes (freq: 0.000037) and Latino in 1 of 34158 chromosomes (freq: 0.000029), but was not observed in the African, Ashkenazi Jewish, European (Finnish) or Other populations. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. The p.Arg1143 residue is conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) provide inconsistent predictions regarding the impact to the protein; this information is not very predictive of pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
not specified Uncertain:1
The p.Arg1143Gln variant in MYH6 has not been previously reported in individuals with cardiomyopathy, but has been identified in 9/15338 South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSN P rs543585784). Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.Arg1143Gln variant is uncertain. -
Hypertrophic cardiomyopathy 14 Uncertain:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1143 of the MYH6 protein (p.Arg1143Gln). This variant is present in population databases (rs543585784, gnomAD 0.04%), and has an allele count higher than expected for a pathogenic variant. This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 27930701, 28611029, 36964972). ClinVar contains an entry for this variant (Variation ID: 228890). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt MYH6 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
MYH6-related disorder Uncertain:1
The MYH6 c.3428G>A variant is predicted to result in the amino acid substitution p.Arg1143Gln. This variant was reported in an individual with dilated cardiomyopathy and heart failure (Table S2 - Haskell et al. 2017. PubMed ID: 28611029) and in a case of sudden death (Sanchez et al. 2016. PubMed ID: 27930701). This variant is reported in 0.043% of alleles in individuals of South Asian descent in gnomAD and is interpreted as uncertain significance by most submitters in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/228890/). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Cardiovascular phenotype Uncertain:1
The p.R1143Q variant (also known as c.3428G>A), located in coding exon 24 of the MYH6 gene, results from a G to A substitution at nucleotide position 3428. The arginine at codon 1143 is replaced by glutamine, an amino acid with highly similar properties. This alteration has been reported once in a sudden unexplained death cohort (Sanchez O et al. PLoS ONE, 2016 Dec;11:e0167358). This variant has also been reported in an exome sequencing cohort (Gorukmez O et al. Am J Med Genet A, 2023 Jun;191:1557-1564). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Cardiomyopathy Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at